BeStock  
Stocks › Biotechnology › PHAT

Phathom Pharmaceuticals PHAT

US equityMarket cap rank #3686Biotechnology
$4.66 −$0.42 (-8.27%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $4.66 0.00%
Open$4.93
Prev close$5.08
Day range$4.62 – $5.15
Volume1.33M
Market cap$378.82M
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-6.0x
CheapRich

Near the bottom of its 5-year range · 4th percentile, 5-year average -2.5x

Price / book-1.4x
CheapRich

Above its usual level · 76th percentile, 5-year average -5.7x

Price / sales1.8x
CheapRich

Around its usual level · 47th percentile, 5-year average 50.1x

#2396 of 5156 stocks by PS (1 = cheapest)

P/E over five years

-8x-5x-2x1xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$5.47
Price vs. fair value-14.9%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB -1.42 – -5.72 76% (pricier than usual) –
PE -6.00 99.02 -2.49 4% (cheaper than usual) –
PS 1.79 1.13 50.07 47% (cheaper than usual) #2396 of 5156 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on PHAT.

Sign in to join the discussion.

Scroll to Top